Stirling was contracted for this clinical trial in late January 2010 and patient recruitment has already commenced and will continue through March 2010.
The study will be conducted in multiple medical centres near Luhansk, Ukraine and involves over a dozen clinicians, including specialists in acute respiratory disease. The benefits of this multi-centre trial include a faster recruitment rate, wider range of population samples, and multiple clinical observers, all such factors supporting a generalized and reliable outcome.
Stirling will provide further advice as this and other clinical trials in Europe and Africa progress during 2010.